Glaucoma Research Foundation Announces $1.6 Million Gift
Main Category: Eye Health / BlindnessArticle Date: 13 Jul 2010 - 4:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Yesterday the Glaucoma Research Foundation announced the largest single gift received in its 32 year history. The $1.6 million gift from the Melza M. and Frank Theodore Barr Foundation is to support the ongoing research of the Catalyst For a Cure consortium to discover a cure for glaucoma. "The Barrs have been very generous in their support of glaucoma research and their gift will have a major impact on the effort to find new treatments and eventually a cure for glaucoma," said Thomas M. Brunner, President and CEO of Glaucoma Research Foundation.
The Catalyst For a Cure research consortium is in its ninth year and takes a unique approach to glaucoma research. Unlike conventional research which often operates in isolation until results can be published, the Catalyst For a Cure was formed with the goal of real time collaboration to speed the process of discovery.
Four principal scientists at four universities brought their experience in neuroscience, genetics, molecular biology and vision to curing glaucoma, the second leading cause of blindness worldwide. Together the team has accelerated the pace of discovery and brought new understanding to vision loss from glaucoma. The principal scientists include Monica Vetter, PhD, University of Utah, Nick Marsh-Armstrong, PhD, Johns Hopkins University, Phil Horner, PhD, University of Washington, and David Calkins, PhD, Vanderbilt University.
Source:
Glaucoma Research Foundation
Visit our eye health / blindness section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/194482.php>
APA
http://www.medicalnewstoday.com/releases/194482.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




